Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Peripheral Arterial Disease Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The global market for peripheral arterial disease treatments experienced robust expansion recently, with projections indicating continued strong performance. This market, valued at $4.74 billion in 2025, is anticipated to reach $5.12 billion by 2026, reflecting a compound annual growth rate of 8.1%. Factors contributing to this growth during the historical period include the widespread occurrence of peripheral arterial disease, a lack of public knowledge regarding its symptoms, a preference for traditional pharmaceutical approaches, insufficient availability of vascular specialists, and a disjointed system for delivering patient care.

The market for peripheral arterial disease is projected for substantial expansion in the coming years, anticipating a rise to $7.28 billion by 2030, driven by a compound annual growth rate of 9.2%. This projected growth is largely fueled by progress in less invasive endovascular techniques, a greater acceptance of drug-eluting devices, the proliferation of healthcare facilities dedicated to PAD treatment, heightened public understanding regarding the importance of early detection, and a more frequent application of multifaceted treatment strategies that combine pharmacological interventions with lifestyle adjustments. Key developments anticipated during this forecast period include the enhanced utilization of artificial intelligence for identifying the disease and evaluating patient risk at an earlier stage, a surge in the deployment of digital and cloud-based systems for patient monitoring, a concentrated effort toward developing personalized PAD treatments based on genetic profiles, a more widespread integration of Internet of Things (IoT) enabled devices for monitoring patients after their treatment, and an increasing incorporation of intelligent manufacturing processes in the production of PAD devices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

Peripheral Arterial Disease Market Growth Drivers And Industry Catalysts

The increasing incidence of diabetes is anticipated to be a significant catalyst for the expansion of the peripheral arterial disease (PAD) market in the future. Diabetes, a long-term metabolic disorder defined by persistently high blood glucose levels, directly contributes to the rising need for interventions and therapies when its prevalence escalates. Individuals with diabetes face an elevated risk of developing atherosclerosis, the primary contributor to PAD, thereby necessitating medical treatment. For illustration, data from March 2024, as released by the UK’s Office for Health Improvement and Disparities (OHID), indicated a 22% surge in the completion rate of eight essential care processes for individuals with type 1 diabetes and a 21% increase for those with type 2 diabetes during the periods spanning from March 2022 to March 2023. Consequently, the surging number of diabetes cases is fueling the expansion of the peripheral arterial disease market.

Peripheral Arterial Disease Market Segment Analysis And Revenue Opportunities

The peripheral arterial disease market covered in this report is segmented –

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Devices: Stents, Balloons, Atherectomy Devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

#Peripheral Arterial Disease Market Trends Influencing Long-Term Demand

Key players within the peripheral arterial disease sector are concentrating their efforts on pioneering novel medical technologies, including intravascular lithotripsy (IVL) catheters, with the overarching goals of elevating treatment effectiveness, bettering patient results, and expediting recovery periods for those afflicted with circulatory ailments. The intravascular lithotripsy (IVL) catheter functions as a medical instrument designed to address arterial obstructions caused by calcification; it achieves this by emitting measured shockwaves that fracture the calcium deposits, thereby facilitating the restoration of blood circulation and enhancing vascular pliability during interventions like angioplasty. As a concrete illustration, in September of 2024, Shockwave Medical, Inc., an American firm specializing in medical technology, introduced its Shockwave E8 peripheral IVL catheter, a device specifically engineered to combat peripheral arterial disease through the application of precise intravascular lithotripsy, employing sonic energy to disintegrate calcium buildups within arterial linings, a revolutionary method that aids in re-establishing blood flow while simultaneously lessening damage to adjacent tissues, with its sophisticated construction enabling improved maneuverability through intricate vascular pathways, rendering it applicable to a broad spectrum of individuals.

Peripheral Arterial Disease Market Leading Players Shaping Industry Direction

Major companies operating in the peripheral arterial disease market are Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC

Access The Complete Peripheral Arterial Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Peripheral Arterial Disease Market Largest Region By Revenue And Market Share

North Americawas the largest region in the peripheral artery disease market in 2025. The regions covered in the peripheral arterial disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.